| Literature DB >> 20087683 |
Abstract
High-dose cyclophosphamide (high-CY) is a potent immunosuppressive regimen that is increasingly used to mitigate both autoimmune and alloimmune conditions. Differential expression of aldehyde dehydrogenase between hematopoietic stem cells and lymphocytes accounts for the differential sensitivity of these cells to high-CY and explains why this regimen is immunosuppressive but not myeloablative. This article describes the clinical translation of high-CY for the treatment of autoimmune and alloimmune conditions.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20087683 DOI: 10.1007/s12026-009-8149-y
Source DB: PubMed Journal: Immunol Res ISSN: 0257-277X Impact factor: 2.829